Selecta Biosciences, Inc.
Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses
Last updated:
Abstract:
Disclosed are synthetic nanocarrier compositions that provide controlled release of immunosuppressants as well as related methods. The synthetic nanocarrier compositions may also include antigen in some embodiments.
Status:
Grant
Type:
Utility
Filling date:
6 Aug 2018
Issue date:
1 Feb 2022